FDA Inspection 899467 — Continental Services Group, Inc.
The FDA completed an inspection of Continental Services Group, Inc. on October 1, 2014 in Ft Lauderdale, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 1, 2014
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ft Lauderdale, FL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 155 | 21 CFR 606.160(b) | Required records |
| 320 | 21 CFR 640.63(c)(5) | Serum protein |
| 81 | 21 CFR 606.100(b)(2) | Donor qualifying tests & measurements |
| 9238 | 21 CFR 630.40(b)(3) | Results of testing |